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Abstract
The rationale of our bioprospecting campaigns is that the extremobiosphere, particularly the deep sea and hyper-arid deserts, 
harbours undiscovered biodiversity that is likely to express novel chemistry and biocatalysts thereby providing opportunities 
for therapeutic drug and industrial process development. We have focused on actinobacteria because of their frequent role as 
keystone species in soil ecosystems and their unrivalled track record as a source of bioactive compounds. Population numbers 
and diversity of actinobacteria in the extremobiosphere are traditionally considered to be low, although they often comprise 
the dominant bacterial biota. Recent metagenomic evaluation of ‘the uncultured microbial majority’ has now revealed enor-
mous taxonomic diversity among ‘dark’ and ‘rare’ actinobacteria in samples as diverse as sediments from the depths of the 
Mariana Trench and soils from the heights of the Central Andes. The application of innovative culture and screening options that 
emphasize rigorous dereplication at each stage of the analysis, and strain prioritization to identify ‘gifted’ organisms, have been 
deployed to detect and characterize bioactive hit compounds and sought-after catalysts from this hitherto untapped resource. 
The rewards include first-in-a-class chemical entities with novel modes of action, as well as a growing microbial seed bank that 
represents a potentially enormous source of biotechnological and therapeutic innovation.
IntRoductIon
Bioprospecting in its widest sense refers to the discovery of 
novel products from biological sources and while bioactive 
therapeutic agents are the most sought after natural prod-
ucts, other economically important targets include biocata-
lysts, plant growth promoters, new feed, food and cosmetic 
components and functional chemicals such as chelating 
agents. The pharmaceutical industry provided the mainstay 
for natural product research but subsequently abandoned 
bioprospecting for a variety of technical and commercial 
considerations including that of the acute rediscovery of 
products. However, a recent upturn of interest in the search 
and discovery of new specialized (secondary) metabolites is 
being driven by innovative research in academe and small 
biotechnology companies and not least due to our ability to 
access an enormously expanded biodiversity through the 
identity and quantification of microbial rare and dark matter. 
These latter categories of organisms have featured strongly in 
our bioprospecting campaigns and merit careful definition: 
rarity refers specifically to very low abundance populations 
within a microbial community and can be defined with a high 
degree of accuracy based on the work of Lynch and Neufeld 
[1], dark microbial matter refers to those organisms that can 
be identified but as yet are uncultivated [2]. Molecular inter-
rogation of environments and of culture collections using 
metagenomic and single-cell genomic techniques is enabling 
dark and rare micro-organisms to be defined in a wide range 
of situations frequently revealing novel Candidatus taxa at the 
supra-generic rank and above. Our bioprospecting activities 
have focused on the phylum Actinobacteria (sensu Good-
fellow [3]), the rationale for which we have rehearsed previ-
ously: unparalleled size and diversity of the taxon, extensive 
global and environmental distribution, continued discovery 
of new taxonomic radiations, genomes rich in natural product 
biosynthetic gene clusters (NP-BGC) and notable ecological 
and economic value. Although members of the genus Strep-
tomyces continue to be the richest source of new actinobacte-
rial specialized metabolites, members of non-streptomycete 
genera as pointed out by Hug et al. [4] increasingly are being 
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shown to produce chemically unique natural products, a fact 
well-illustrated by our work with Verrucosispora [5], Derma-
coccus [6] and Lentzea [7].
thE paRadIgm shIft
We will start by discussing the questions of where to look 
and how to look in the context of bioprospecting. Our prior-
itization of the extremobiosphere for bioprospecting has 
been based on the likelihood that it contains novel micro-
organisms that express new chemistry and metabolism, 
which in turn stimulates innovative biotechnology. The term 
extremobiosphere defines the environmental limits to life on 
Earth and encompasses the extreme boundaries of the known 
physico-chemical world; the extremobiosphere is character-
ized by various combinations of extreme temperature, pH 
and aridity, intense radiations, hyperbaric pressure, anoxia, 
strong oxidizing conditions, high salinity, oligotrophy, xeno-
biotic pollution and toxic elements (e.g. As, Cu, Pb). Here it is 
important to distinguish between extremophilic and extremo-
trophic (also known as extremotolerant) actinobacteria [8]; 
to date, the majority of isolates from the extremobiosphere 
appear to express extremotrophic phenotypes.
The decisive change in bioprospecting has resulted from how 
to detect novelty at the organism level, that is the shift from 
culture-dependent to culture-independent microbiology 
resulting in the ability to distinguish and identify rare and dark 
biodiversity. Our own realization of the scale of actinobacte-
rial dark matter first resulted from analyses of deep Atlantic 
Ocean sediments [9], which revealed that between 86 and 
94 % of the clone libraries examined represented putatively 
novel taxa (estimates based on 16S rRNA sequence identity of 
98.7 % [10, 11]; or 38–71 % novelty based on the previously 
advocated 97 % sequence identity [12]). Other more detailed 
examples of dark and rare populations are discussed below.
It should be noted also that significant developments have 
occurred regarding the detection and identity of natural 
products. Established approaches such as bioassay-guided 
screening coupled with compound purification and structure 
determination, and metabolomics (chemical fingerprinting of 
an organism, i.e. the product of genotype and environment), 
have been complemented by genome-based techniques such 
as mining of whole and metagenomes, and crucially by data-
base developments designed to promote chemical dereplica-
tion [13].
BIopRospEctIng BIomEs and sItEs
Our bioprospecting campaigns have targeted major extreme 
biomes and within them distinct sites displaying various 
degrees of environmental extremities. Thus, the choice of 
deep sea and desert biomes provides strong selective pres-
sures, for example in hyperbaric pressure and aridity respec-
tively, that determine the composition of their actinobacterial 
communities.Fig. 1 shows the global distribution of extreme 
biome sampling sites that we have researched and which, 
in addition to the principal focus on deep seas and deserts, 
also has included polar, thermal and volcanic environments. 
Specific details of these sites are given in Table 1, where the 
range of altitude over which our ‘bioprospecting campaigns’ 
Fig. 1. Global distribution of extremobiosphere sites sampled during 1992–2017.
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have unfolded is evident; a pictorial representation of this 
mega range of depth and elevation is featured in Fig. 2.
Before highlighting some of the scientific outcomes from 
this 16 000 m exploration we direct attention to the salient 
properties that define the two major biomes that we have 
surveyed. Deep seas are generally defined as marine envi-
ronments of greater than ca. 200–500 m depth and which 
were once regarded as being biologically inert (Forbes’ azoic 
theory [14]), a notion that was dispelled in the late nine-
teenth century. Abundant life and biodiversity is now well-
documented even at abyssal (>2 000 m) and hadal (>6 000 m) 
depths and actinobacteria have been isolated from sediments 
taken at all of these extremes [8, 15–18]. Conditions found in 
these oceans include high pressure, temperature and salinity 
extremes, low nutrient status and anoxia. Although our ocean 
bioprospecting has been made over a wide geographic range 
and included coastal and remote marine locations it cannot 
claim to be systematic either in terms of depth or ocean condi-
tions, a situation that stems from the major logistical problems 
associated with sampling these environments [it is sobering to 
note that the ultra-deep robotic vehicles Kaiko (Japan Agency 
for Marine-Earth Science and Technology, JAMSTEC) and 
Nereus (Woods Hole Oceanographic Institution) both were 
lost during research missions].
In addition to many of the environmental conditions cited 
above that characterize the extremobiosphere, that of severe 
aridity is probably the most defining for the existence of 
microbial life in deserts, indeed the core region of the Atacama 
Desert in northern Chile has been designated ‘the dry limit of 
microbial life’ [19]. Moreover, high mountain desert habitats 
that include the Chajnantor plateau (see below) are subject 
to a combination of extreme environmental conditions 
including the world’s highest levels of surface UV radiation 
[20]. Access to all of the major habitats in the Atacama Desert 
have enabled our bioprospecting campaigns to adopt a more 
systematic approach and have encompassed hyper-arid and 
extreme hyper-arid soils (sensu Houston [21]), altitude gradi-
ents, and saline and geothermal environments. From each of 
these habitats we have recovered viable actinobacteria and/
or obtained DNA evidence for their presence.
BIopRospEctIng outcomEs
Novelty both of actinobacterial diversity and chemical diver-
sity has been detected and characterized unequivocally over 
the complete depth-altitude and geographic ranges of our 
bioprospecting campaigns. Highlighted results are considered 
first in terms of taxonomic novelty followed by new natural 
product chemistry produced by novel representatives of deep 
sea and desert species.
actinobacterial diversity
Initial studies of deep sea actinobacteria were founded on 
culture-dependent surveys where our collaboration with 
JAMSTEC enabled sediments from a complete range of ocean 
depths (289–10 898 m) to be examined. With the exception 
Table 1. Extremobiosphere sites sampled for actinobacteriaa
Deep sea Pacific Ocean: 1. East: Sagami Bay (1168 m), Suruga Bay (1151–1948 m), Sea of Japan (289 m), Ryukyu Trench (5110–
6600 m), Izu-Bonin Trench (2670–9780 m), Mariana Trench (10897 m)
2. West: Golfo Corcovaclo (200 m)
Atlantic Ocean: 1. Mid: Canary Basin (3814)
2. North: Raune Fjord (187 m), By Fjord (316 m), Norway
Indian Ocean: Indus Rise
Polar Antarctica: Terra Nova Bay, Edmundson Point
Thermal Indonesia, Java Dieng Volcanic Complex (2000 m)
Chile El Tatio geothermal field (4320 m)
Volcanic Indonesia, Java Tangkuban Perahu, Bandung (2000 m)
Gunung Merapi, Yogyakarta (1500 m)
Desert Australia, Northern Territory East of Kings Canyon
Namibia Kalahari Desert, Waterberg
Chile 1. Atacama Desert: Yungay (915–1015 m), Salar de Atacama (2220–2300 m), Cordillera de Sol (2470–
2540 m), Lomas Bayas
2. Altiplano: Salar de Tara (4366 m)
3. Central Andes: Cerro Chajnantor (3000–5000 m)
a, Depths and elevations given in metres.
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of Mariana Trench samples, actinobacteria initially were 
isolated from all depths and evidence obtained to support 
the hypothesis of indigenous taxa, especially in the very 
deep Ryukyu, Izo Bonin and Japan Trenches [22]. Among 
the genera detected were Corynebacterium, Dietzia, Gordonia, 
Mycobacterium and Rhodococcus and 16S rRNA phylotyping 
indicated putative new species within several of these taxa 
while recent phylogenomic analyses show that rhodococci 
belong to several lineages that can be equated with genera 
[11, 23]. Moreover, simulated deep sea conditions confirmed 
that these actinobacteria grew at the sediment salinities and 
temperatures from which the isolates were recovered while 
a number of abyssal and hadal rhodococci were capable of 
growth at hyperbaric pressures (40–60 MPa). Subsequent 
efforts resulted in the isolation of three new species of Derma-
coccus one of which, D. abyssi, was piezotolerant [15, 16]. 
Other examples of novel actinobacterial diversity are treated 
in relation to natural product discoveries.
Actinobacteria are globally distributed in the world’s oceans, 
particularly in marine sediments [24, 25]. We referred briefly 
above to the analysis of sediment cores taken in the Atlantic 
Ocean near to the Canary Basin. New primers designed 
specifically for actinobacteria were used in the construction of 
clone libraries from sediment sections at depths up to ca. 1 m 
below the ocean floor and diversity statistics applied to define 
actinobacterial library coverage, taxonomic richness and 
phylogenetic diversity. Significant differences were observed 
in the taxonomic diversity as a function of sediment depth, 
but both taxonomic richness and phylogenetic diversity 
decreased with depth [9]. Statistical diversity estimators such 
as those used in this study provide a powerful bioprospecting 
adjunct. Culture-independent analysis of the Canary Basin 
sediment also yielded clones of the obligate marine genus 
Salinispora [24] pointing to its wider biogeographical distri-
bution in terms of ocean temperature and depth than previ-
ously reported.
The main efforts of our arid biome prospecting have focused 
on the Atacama Desert where actinobacteria are a dominant 
taxon in many habitats including those defined as extreme 
hyper-arid. Culture-based surveys of recent years have 
Fig. 2. A 16 000 m extremobiosphere bioprospecting campaign
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reported members of over 23 validly named genera and 
many new and putatively new species have been highlighted 
including ones belonging to the poorly studied genera Acti-
nomadura, Cryptosporangium, Kribbela, Nonomuraea, Pseu-
donocardia and Saccharothrix [26, 27]. However, it is only 
from the results of metagenomic surveys that the spectacular 
extent of actinobacterial diversity in Atacama habitats has 
been fully recognised [28, 29]. The data in Table 2 show the 
massive extent of actinobacterial dark matter existing at supra-
generic ranks while at the genus rank 234 and 297 phylotypes 
were detected at low and high altitude sites, respectively. High 
proportions (43–54 %) of genuinely rare taxa (sensu Lynch 
and Neufeld [1]) were also detected. Preliminary evidence 
was advanced for an Atacama Desert core microbiome of 
actinobacteria (sensu Shade and Handelsman [30]) and it 
will be interesting to discover if this is a characteristic of the 
Atacama or represents that of global desert biomes.
Bioactive natural products
The impressive array of members of chemical classes found 
in actinobacteria recovered from the two selected extreme 
biomes is shown in Table 3, which, with the exception of the 
abenquines [31], have been discovered by our group. Each of 
these products represents a new-in-a-class or first-in-a-class 
chemical. Similarly, a range of bioactivities is presented by 
these compounds with antibacterial and anticancer activi-
ties being the most widely distributed. The occurrence of 
phosphodiesterase and glycogen synthase kinase inhibitors 
is notable in providing potential therapeutic targets for anti-
inflammatory diseases, and Alzheimer’s disease and type II 
diabetes, respectively. However, in the overall context of drug 
discovery and development it should be stressed that at this 
stage these compounds are simply putative drug hits; never-
theless, it is encouraging that within a short time following 
their discovery several have been synthesized chemically thus 
opening up the way to enhance efficacy and/or ameliorate 
cytotoxicity via structural modification.
While the strategies used for detecting microbial special-
ized metabolites are well-established (bioassay-guided, 
metabolomics, genome mining and sequencing [32–34]) 
those used to elicit the expression of their biosynthetic 
gene clusters (BGC) have arisen either by more random or 
intuitive routes such as the one strain-many compounds 
scheme involving variations of the fermentation protocol, 
and co-culture systems. The latter approach appears not to 
have been tested extensively but two examples arising from 
our Atacama Desert work have produced interesting and 
unpredictable results. Co-cultivation of the Chaxa de Laguna 
isolate Streptomyces bullii KBCC15426T with a strain of Asper-
gillus fumigatus resulted in the synthesis of nine specialized 
metabolites none of which were produced by axenic cultures 
of either partner [35]; while co-culture of the fungus with 
Table 3. Natural product diversity of actinobacteria cultured from deep 
sea and hyper-arid desert
Chemical class Natural producta Source Bioactivity
Amino furan 
polyamides





Spicamycins A-E Yungay (1016 m) 2
Aminoquinones Abenquines A-D Salar de Tara 
(4500 m)
1, 6
Ansamycins Chaxamycinsa Laguna de Chaxa 
(2300 m)
1, 2
Benzoxazoles Benzoxacystol Canary Basin 
(3814 m)
2, 7










Yungay (1016 m) 1*
Macrolactones Atacamycins Laguna de Chaxa 
(2300 m)
2, 6
Chaxalactins A-C Laguna de Chaxa 
(2300 m)
1
Peptides Chaxapeptin Salar de Atacama 
(2219 m)
1, 2





Abyssomicins Sea of Japan 
(289 m)
1, 2, 5
Levantilide C Golfo Corcovaclo 
(200 m)
2
(1) Antibacteria, (1*) antibacteria including Gram-negative, (2) 
anticancer, (3) antioxidant/radical scavenging, (4) antitrypanosome, 
(5) anti-HIV-1 integrase/HIV reactivator, anti-HIV and HIV 
replication inducer, (6) phosphodiesterase (PDE-4B2) inhibitor, (7) 
glycogensynthase kinase 3b inhibitor.
a, Compounds that have been synthesised chemically.
Table 2. High taxonomic rank dark matter among Atacama 
actinobacteria
Median altitude ecosystems (915–1540 m)
 
No. of families detected 67
Candidatusa Families 14 (21  % total)
High altitude ecosystems (3000–5000 m)
No. of families detected 55
Candidatus families 19 (35 % total)
Candidatus classes 2 (increase of 33%)b
Candidatus orders 4 (increase of 22%)b
a, Candidatus defines well-characterized but as yet uncultured 
organisms.
b, Putative new taxa in addition to those validly published.
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Streptomyces leeuwenhoekii strain C34T elicited synthesis 
of the lasso peptide chaxapeptin not previously detected in 
extracts of this strain. Moreover, chaxapeptin synthesis by 
the known producer strain of S. leeuwenhoekii (C58) was 
significantly increased when it was co-cultured with A. 
fumigatus [36]. It can be argued that such discoveries are at 
best fortuitous and serendipitous although the co-culture of 
organisms renowned for their abilities to produce special-
ized metabolites can be viewed as a sensible starting point. 
Future ecology-guided prospecting along these lines could 
profit from defining the originating microbial communities 
per se, and using continuous culture systems for analysing 
evolutionary trends within such communities [37].
Detailed information on all of the compounds reported in 
Table 3 is available in primary publications but here we refer 
to selected ones in order to highlight some salient aspects of 
the bioprospecting process.
abyssomicins
These spirotetronate polyketides, first isolated from the 
deep sea Verrucosispora maris AB-18-032T, and detected by 
assay-guided screening possess a unique chemical scaffold 
and antibacterial mode of action [5]; they are among those 
dubbed ‘inspirational natural products’ by Nicolaou [38]. 
Subsequently members of this chemical class have been 
found in species of Streptomyces and currently 32 natural 
abyssomicins and many chemically synthesized analogues 
have been described [39]. Following the defining of anti-
Gram-positive bacteria activities [including methicillin- and 
vancomycin-resistant Staphylococcus aureus (MRSA and 
VRSA)], particular abyssomicins have been shown to express 
anti-TB and anticancer properties, to reactivate latent human 
immunodeficiency virus (HIV), induce HIV replication, and 
to have anti-HIV action. To our knowledge, none of these 
diverse abyssomicin attributes has yet led to pharmaceutical 
development but the recent resurgence of interest coupled 
with an increasing ability to improve drug efficacy and lower 
toxicity via medicinal chemistry holds promise for such pro-
drug development. The excellent review of Sadaka et al. [39] 
elaborates these and related aspects of the abyssomicin family.
dermacozines
This new ten-membered family of phenazines was detected 
by metabolite screening and is notable for its discovery of 
a novel piezotolerant species of Dermacoccus isolated from 
the deepest oceanic trench on Earth [6, 40]. Several of the 
dermacozine analogues displayed moderate activity against 
a human leukemia cell line and one (dermacozine C) has 
antioxidant titres greater than that of ascorbic acid. The total 
synthesis of dermacozines A and B was reported recently [41].
chaxamycins
These new ansamycin antibiotics were detected using a 
genome mining approach that targeted the gene encoding 
3-amino-5-hydroxybenzoic acid synthase [42]. The producing 
bacterium was characterized as S. leeuwenhoekii and assigned 
as the representative of a deeply rooted 16S rRNA gene clade 
(C34, see below). In addition to their antibacterial activities 
(including highly selective anti-MRSA) chaxamycins are 
promising anticancer agents. To date total chemical synthesis 
of chaxamycins has not be reported although synthesis of 
the polypropionate stereocentres has been successful [43]. 
This latter achievement and the promise of mutasynthesis 
with this strain [44] recommend routes for producing novel 
chaxamycin analogues having enhanced and/or expanded 
bioactivity.
chaxapeptin
This novel class II lasso peptide inhibits cell invasion activity 
in a human lung cancer cell line. It was discovered by genome 
mining of another member of the S. leeuwenhoekii clade 
(C58) [45] and, as noted above, its fermentation titre can be 
increased effectively by co-culture.
genome analysis
Genome sequences of three of the deep sea and six of the 
desert actinobacteria discussed above have been obtained 
recently (Table 4); most of these are draft sequences and only 
that of S. leeuwenhoekii C34T is a full, high-quality sequence 
[46]. The GC contents of these strains were typical for actino-
bacteria ranging from 70.6 to 74.0 mol %.
Genomes of members of the family Geodermatophilaceae 
isolated from extreme hyper-arid soils were relatively small 
(3.89–5.51 Mb) but contained a high proportion of genes 
related to environmental stress response including heat 
and cold shock responses, osmotic stress, carbon starvation 
and stress factors that give rise to reactive oxygen species 
[28, 29, 49]. Perhaps surprising is the high capacity of these 
bacteria to synthesis specialized metabolites, a feature also 
noted in novel species of Micromonospora isolated from 
extreme hyper-arid Lomas Bayas soil [52], the assump-
tion being that competitive success in extreme, sparsely 
populated ecosystems might be more likely determined by 
stress resistance rather than by antibiosis. The genomes of 
all the Atacama actinobacteria included in Table 4 contained 
large numbers [35–46, 49, 52, 56–71] of biosynthetic gene 
clusters (BGCs), a fact that promises well for bioprospecting 
action. However, the findings from draft sequences should 
be interpreted with some caution given problems associated 
with sequence coverage and mis-assemblies of contigs using 
some sequencing platforms and failure to distinguish between 
BCGs encoding for natural products and primary metabolites 
[46, 56]. Such caveats notwithstanding, draft sequences have 
proved effective in genome mining prospecting as exemplified 
by chaxamycin and chaxapeptin discovery.
Regarding genome characteristics, are we justified in 
describing our extremobiosphere isolates as ‘gifted’, a concept 
introduced by Richard Baltz to define micro-organisms 
having large genomes, preferably greater than 8 MB, and 
encoding 20–50 BGCs [56], or ‘biosynthetically talented’, 
as other authors describing large actinobacterial BGCs 
have advanced [54]? While only Amycolatopsis vasitatis and 
S. leeuwenhoekii strain C34T meet this requirement in the 
Downloaded from www.microbiologyresearch.org by
IP:  129.12.60.111
On: Tue, 25 Jun 2019 14:38:05
7
Bull and Goodfellow, Microbiology 2019
strictest sense (Table 4; [46]), it is remarkable that some of 
the small genome actinobacteria isolated from the extreme 
hyper-arid core of the Atacama Desert displayed even 
greater capacities for specialized metabolite production. 
Clearly chemical screening of these latter members of the 
family Geodermatophilaceae deserve prior attention. Never-
theless, bioprospecting campaigns should remain focused 
on the detection of cultivable actinobacteria with large 
genomes given their propensity to produce novel drug-like 
compounds [33, 56]. Metagenomic analyses have shown that 
such gifted actinobacteria are a feature of natural habitats 
[57, 58]. Creative cultivation techniques are available for the 
isolation of rare and novel actinobacteria with large genomes 
[27, 59], though there is a need to marry innovative selective 
isolation procedures with the ecology of target organisms 
[60–63], as demonstrated by adaptations shown by Salinis-
pora and Streptomyces strains [64, 65]. There is also a need 
to obtain complete genome sequences from especially gifted 
actinobacteria [33, 34] for systematic genome mining for new 
molecules.
WhIthER BIopRospEctIng?
By way of concluding this review we pose a number of 
questions that should influence decisions on whether or 
not to engage in bioprospecting. We preface these questions 
by a brief aside on the necessity of being granted official 
permission to access prospecting sites (often located within 
countries deemed to be less-developed and/or reservations 
of indigenous peoples and that have minimal relevant exper-
tise); of effective collaboration with in-country personnel; of 
joint reporting and benefit sharing; and of being cognizant 
of the Convention on Biological Diversity and the Nagoya 
Protocol.
Why bother with natural products?
The fact that natural products occupy a much greater area 
and variety of chemical space and chemical scaffolds than 
combinatorial synthetic compounds provides a compelling 
a priori reason for prioritizing them in the search for novel 
drugs. The former problem of rediscovery of products is now 
greatly minimized or prevented by sophisticated methods 
for organism and chemical dereplication [66]. It is becoming 
apparent that expanded chemical novelty is to be found by 
screening rare or poorly researched microbial taxa particularly 
among actinobacteria (e.g. the discovery of abyssomicins, 
proximicins and lentzeosides in novel species of Verrucosis-
pora and Lentzea, respectively). Genomic-guided identifica-
tion of new drug targets such as protein–protein interactions 
also will stimulate natural product bioprospecting given the 
extent of such interactions in nature. Moreover, as Hug et 
al. [4] point out if production scale cultivation of target 
organisms compromises the exploitation of a promising 
natural product, culture-independent strategies that include 
metagenomics and heterologous expression of BGCs provide 
exciting approaches for the discovery of novel natural prod-
ucts among biosynthetic dark matter, as does the prospect of 
coupling genome sequencing with synthetic biology [33, 34].
Is focus on the extremobiosphere justified?
We note first that the extent of the known extremobiosphere 
has increased dramatically during recent times, most notably 
with the exploration of the marine deep biosphere [67], the 
deepest sediment analysed at 1626 m [68]; deep terrestrial 
boreholes [69]; and high elevation barren tephra (Volcan 
Llullaillaco, Atacama region 6330 m [70, 71]). Prokaryotic 
life has been detected in each of these environments using 
culture-dependent and culture-independent methods 
and, interestingly, actinobacteria have been reported to be 
among the dominant bacteria. Members of a large number 
Table 4. Genome characteristics of deep sea and Atacama Desert actinobacteria
Species Genome size (MB) tRNAs Contigs DNA GC content 
(%)
BGCs
Verrucosispora marisa 6.7 51 20
Streptomyces sp. strain NKT397b 7.44 81 71.9 37
Blastococcus atacamensisc 3.89 53 163 73.1
Modestobacter caceresiid 4.96 50 139 73.6 48
Geodermatophilus chilensise 5.51 52 374 74 56
Micromonospora aridaf 7.15 56 345 71 54
Micromonospora inaquosag 7.75 58 408 70.6 64
Streptomyces leeuwenhoekii strain C34h 8.29 65 1 72.6 35
Amycolatopsis visitatisi 10.67 70.8 38
a, Roh et al. [47]; b, Olano et al. [48]; c, Castro et al. [49]; d, Busarakam et al. [50]; e, Castro et al. [51]; f, g, Carro et al. [52]; h, Busarakam et al. [53], 
Gomez-Escribano et al. [54]; i, Adamek et al. [55], Idris et al. [28].
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of actinobacterial genera have been reported in subseafloor 
sediments over 1 km in depth [72]. While recognizing that 
more mundane environments can contain novelty for the 
bioprospector (e.g. forest soil [73], street sediments [74]) we 
opine that the case for prioritizing extreme biomes is sound as 
it moves bioprospecting action away from well-probed terres-
trial streptomycetes towards microbial communities that have 
evolved under harsh selective conditions during the course of 
which novel biochemistry has been generated [75]. As Rateb 
et al. report [66], a total of 46 natural products representing 
diverse chemical classes have been isolated from Atacama 
Desert actinobacteria during the past 7 years. Symbiotic asso-
ciations frequently have evolved in harsh selective environ-
ments and there is increasing recognition of them producing 
a wealth of new chemical space in insect [76] and marine 
invertebrate [77] mutualisms, for example. The discovery 
of novel antimicrobial pentacyclic polyketides produced by 
Streptomyces formicae [78] isolated from a fungus-growing 
plant-ant illustrates very effectively the benefits of exploring 
under-investigated ecosystems for the discovery of micro-
organisms having the capacity to synthesize novel natural 
products [79].
Is biogeography a roadmap to drug discovery?
In the context of bioprospecting a secondary question arises: 
is everything everywhere? While avoiding another discussion 
of this long-proposed hypothesis (see [80]) we believe that 
increased efforts to investigate phylogeographic distribution 
of micro-organisms is a relevant objective. A landmark study 
of fluorescent Pseudomonas genotypes showed that these soil 
bacteria were not mixed globally [81] and more recent studies 
of Streptomyces populations [82, 83] support the notion of 
geographic distinction. Streptomyces diversity was found to 
vary as a function of geographic distance and, moreover, 
phenotypes showed regional endemism with respect to 
antibiotic production and resistance, features that are likely 
to encourage global bioprospecting campaigns. At a global 
level, Charlop-Powers et al. [57] probed a large collection of 
environmental samples for selected biosynthetic genes and 
found that geographic location and biome type were the 
most important factors related to their sequence diversity. 
Moreover, the diversity and endemicity of actinobacteria 
in fragile desert habitats such as the extremely oligotrophic 
Cuatro Cienegas Basin in the Chihuahuan desert presents 
an invaluable source of biological material for ecological and 
bioprospecting studies [84].
how rational can we make bioprospecting?
In this context, logic can be applied to the selection of biomes 
and geographic locations, and the prioritization of organisms 
with regard to novel chemistries. We have touched on the 
former issues and here consider arguments for prioritizing 
organisms in bioprospecting projects, the overall case for 
actinobacteria having been made repeatedly [26, 27]. Previ-
ously we have emphasized the need for taxonomic rigour in 
order to define novelty, establish strain dereplication, predict 
metabolic potential and guide selective isolation procedures 
[85–87]. And underlying such an admonition is the knowl-
edge that prokaryotic systematics currently exists in such 
a dynamic state that genome-based classification is likely 
to become the norm [11]. Actinobacteria provide a case in 
point where analyses of genome-scale data have prompted 
significant revision of taxonomic and evolutionary relation-
ships within this phylum [88], including the reclassification of 
Verrucosispora species in the genus Micromonospora.
The advent of genomics now enables natural product poten-
tials of target bioprospecting taxa to be determined and hence 
prioritize screening options. Recent comparative genomics 
of the genus Amycolatopsis, a large, widely distributed genus 
well-known as a source of bioactive metabolites, illustrates the 
power of this strategy. The pan-genome of members of this 
genus comprises a small core genome largely involved with 
translation and ribosome biogenesis and a ‘huge’ accessory 
genome that includes numerous genes encoding biosynthesis 
of specialized metabolites [55]. Phylogenetic analysis of the 
genus revealed four distinct lineages that correlated perfectly 
in their capacities to produce specialized metabolites; 
moreover, the extensive diversity of BGCs revealed that the 
majority were unique to Amycolatopsis. Such discontinuous 
distribution of natural product bioclusters within a target 
taxon underlines the importance of rigorous classification in 
bioprospecting. Within the strain library used in this study 
was the high BGC containing, newly described A. vastitatis 
isolated from Cerro Chajnantor soil at 4000 m [89]. Similar 
conclusions can be drawn from phylogenomic studies on 
representatives of the genus Micromonospora [90]. Amongst 
actinobacteria, micromonosporae are second only to strepto-
mycetes in their ability to synthesize natural products, notably 
antibiotics, including ones that are not only in clinical use [32] 
but considered essential to global health [91]. Interestingly, 
the application of innovative selective isolation procedures 
has shown that micromonosporae are a feature of diverse 
Atacama Desert soils [92].
Without question, the awareness of silent NP-BGCs in 
microbial genomes, aided by bioinformatics software for their 
analysis, is beginning to have a major impact on the identity 
and expression of new chemical entities. The challenge now, as 
pointedly stated by Zhang and Moore [93] is how to translate 
sequence information into chemical reality, and ‘to access not 
just small variations in old chemistry, but completely new 
chemical scaffolds’. In a valuable discussion of the means of 
activating such BCGs Baral et al. [94], while acknowledging 
that to date no single superior methodology is available, high-
light three approaches for harnessing new natural products: 
pleiotropic methods aimed at modifying the whole genome; 
BCG-specific methods, including heterologous expression; 
and, targeted genome-wide methods that focus on previously 
identified BCGs of interest.
Is it appropriate to continue with culture-dependent 
searches?
The impressive developments in culture-independent 
methods of detecting and characterizing dark and rare 
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components of microbiomes notwithstanding, we affirm 
that cultivation-based approaches have an integral role in 
bioprospecting. For example, the availability of organisms 
per se enables one strain-many compounds and co-culture 
screening options and may provide for rapid pre-screening of 
large communities of actinobacteria via colour-group analysis 
[27]. Indeed, Baltz [33, 56] makes a strong claim in this 
context asserting that major resurgence in natural product 
discovery will be facilitated by focusing heavily on cultur-
able, gifted organisms while expressing reservations on the 
success of mining microbes from the unculturable majority 
for natural products. The imperative therefore is to develop 
innovative procedures for bringing members of the dark 
and rare actinobacterial populations into culture and here 
functional metagenome mining of extremobiosphere will 
provide information on ecophysiology and hence vital clues 
for designing isolation media and incubation conditions.
can any advantage be gained from screening 
subspecies of organisms?
Probably as a consequence of effort involved and intuition, 
information on this point is limited but our experience with 
the gifted species S. leeuwenhoekii bears comment. A large 
well-delineated clade of Streptomyces was isolated from 
soils of the Salar de Atacama [95], a representative member 
of which was subsequently published as the new species S. 
leeuwenhoekii [53]. Four members of a subclade of this species 
sharing 99.5–99.9 % 16S rRNA sequence identity have been 
shown to have differential capacities to produce bioactive 
specialized metabolites that include chaxalactins (strain 
C34T), atacamycins (C38), chaxapeptin (C58) and novel 
compounds (C79) [46]. The recent report from Park and 
Andam [96] on strain-level variation in the distribution and 
abundance of BGCs in Streptomyces rimosus emphasizes the 
importance of screening multiple strains of the same species 
in natural product discovery campaigns. Individual S. rimosus 
genomes were shown to have a unique repertoire of BGCs 
that ranged from 35 to 71 clusters per genome. In future, such 
studies can be undertaken with increased confidence now 
that a digital DNA homology cut off of 79 % can be used to 
circumscribe subspecies [97] as illustrated by Nouioui et al. 
[88]. This should help to avoid the delineation of ill-defined 
subspecies; detailed taxonomic analyses of the type strains 
of subspecies of Streptomyces hygroscopicus and Streptomyces 
lavendulae, for instance, showed that the former merited 
recognition as distinct species within the genus Streptomyces 
[98] whereas the latter formed a genomic species together 
with the type strain of S. lavendulae [99]. Further, the circum-
scription of ecovars of gifted actinobacterial species such as 
Streptomyces griseus may allow the development of predictive 
models for explaining the distribution of novel NP-BGCs in 
defined habitats [60, 100].
What is the feasibility of managing bioprospecting 
information overload?
Given the rapid accumulation of genomic and metagenomic 
sequences, and the ever-increasing size of chemical libraries 
and microbial culture collections, bioprospecting is not 
immune from information overload, hence the need for effec-
tive search and analytical tools. While this is not the place for 
a detailed discussion of the problem, two recent examples 
illustrate the type of approaches being made to manage large 
data sets.
Extracts from a collection of a 1000 largely taxonomically 
uncharacterized marine bacteria were screened by LC–MS/
MS-based metabolomics and the data subjected to molecular 
networking [101]. Coupled with high throughput culturing 
such a procedure enabled rapid dereplication and the detection 
of novel metabolites. The incorporation of multiple culture 
extraction systems significantly extended the chemical space 
covered in this project but manual curation of the resulting 
data sets, having the magnitude of hundreds of thousands 
of different MS features, would not have been feasible. The 
authors conclude that the strength of their protocol lies in its 
untargeted nature: ‘Without reliance on genetic, geo-graphic 
or other data, large numbers of randomly sampled organisms 
can be prioritized…and guide investigators towards novel 
molecules’. Our second example refers to the prioritization of 
bacterial collections for the production of the potent bioactive 
enediyenes. Preliminary screening of a bacterial collection by 
our group [102] using library-on-a-slide technology resulted 
in a hit rate of 15 % from which PCR and sequencing of posi-
tives enabled the identification of novel enediyene PKS genes. 
More recently, Yan et al. [103] have surveyed a much larger 
bacterial collection (3400 strains) also based on enediyene 
PKS cassettes and showed that the positive strains fells into 
28 distinct phylogenetic clades each of which contained 
a distinct enediyene BGC. Subsequent development of a 
genome neighbourhood network enabled new enediyene 
chemistry to be predicted again demonstrating the feasibility 
of rapid discovery of new natural products from a large strain 
collections.
conclusIon
We conclude by reasserting our optimism in microbial natural 
products as a source of new therapeutic agents and that the 
Earth’s extremobiosphere provides propitious opportunities 
for successful bioprospecting. Decisive technical advances in 
microbiology, molecular biology, bioinformatics and chem-
ical screening give credible support to this optimism while 
natural product hits that initially appear to fail the tests of 
druggability on the basis of toxicity or other properties can be 
further explored by the intervention of medicinal chemistry. 
Although this review has focused on the search for putative 
new drugs, the extremobiosphere is a rich source of other 
natural products not least research enzymes and industrial 
biocatalysts [104], and compounds with the potential to 
promote the growth of actinorhizal plants in polluted and 
nutritionally poor saline soils [105].
The primary requirement, and concern, for successful 
bioprospecting is the availability of microbial gene pools, 
an objective that can be met by access to diverse habitats, 
culture collections and genome data banks. However, 
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worldwide habitat destruction, large-scale crop monocul-
ture, mining and power generation should be of increasing 
concern to microbiologists, as should the effect of climate 
breakdown, as witnessed by the destruction of microbial 
communities in the hyper-arid core of the Atacama Desert 
following highly unusual rain events [106]. Although such 
problems and suggested ways of safeguarding microbial 
diversity have been voiced from time to time, ‘formulating a 
consistent environmental ethic for the conservation of micro-
organisms is notoriously difficult’ (Cockell and Jones [107]). 
In a very thoughtful analysis, the latter authors have set out 
priorities for microbial conservation and proffer practical 
means for its advancement ranging from a strengthening 
of ecosystem research to adapting legislation to provide 
special protection for ecosystems that are acknowledged to 
contain critically important microbial communities. Progress 
towards achieving such objectives has not been impressive 
and we conclude by strongly commending the entreaty made 
by Cockell and Jones for institutions such as conservation 
organizations, learned societies and university centres to take 
more active roles in broadcasting the case for and promoting 
microbial conservation.
dedication
This paper is dedicated to the memory of the late Martin 
Alexander (1930–2017) of Cornell University, outstanding 
microbiologist, committed internationalist and humanitarian, 
and meticulous but compassionate mentor, and all aspects of 
his philosophy that he passed onto the scientific community.
postscript
This review marks the collaboration of the authors in 
bioprospecting over more than a quarter century; it reflects 
their philosophy regarding search and discovery, highlights 
some of the concepts and practices that have inspired their 
research, and, by provoking a number of questions relating 
to bioprospecting, attempts to encourage further work in this 
field.
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